Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,806 USD | -8,39% | -16,04% | +39,09% |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Placenta-Based Cell Therapy
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +22,65% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +22,65% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yaky Yanay
CEO | Chief Executive Officer | 52 | 01-11-06 |
Director of Finance/CFO | 40 | 01-05-13 | |
Zami Aberman
CHM | Chairman | 70 | 26-09-05 |
Artur Machlenkin
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-22 |
Nitsan Halevy
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
Lior Raviv
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-11 |
Orly Amiran
PRN | Corporate Officer/Principal | - | - |
Nimrod Bar Zvi
PRN | Corporate Officer/Principal | - | - |
Efrat Kaduri
PRN | Corporate Officer/Principal | - | 01-10-14 |
Human Resources Officer | 62 | 01-01-07 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | 15-07-21 | |
Lorne Abony
BRD | Director/Board Member | 55 | 11-07-23 |
Zami Aberman
CHM | Chairman | 70 | 26-09-05 |
Yaky Yanay
CEO | Chief Executive Officer | 52 | 01-11-06 |
Director/Board Member | 54 | 06-01-21 | |
Director/Board Member | 61 | 01-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 41 480 172 | 31 185 312 ( 75,18 %) | 0 | 75,18 % |
Bedrijfsgegevens
Pluri, Inc.
MATAM Advanced Technology Park Building No. 5
3508409, Haifa
+972 74 710 8600
http://www.pluri-biotech.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,09% | 36,49 mln. | |
+9,30% | 45,97 mld. | |
+52,73% | 43,93 mld. | |
+7,15% | 42,34 mld. | |
-8,78% | 28,27 mld. | |
+18,68% | 27,18 mld. | |
-21,92% | 19,44 mld. | |
+14,62% | 13,83 mld. | |
+31,85% | 12,4 mld. | |
+4,47% | 11,45 mld. |
- Beurs
- Aandelen
- Aandeel Pluri Inc. - Nasdaq
- Onderneming Pluri Inc.